Skip to main content

The Neuroendoscopes market to remain unfazed by the Global Recession

 In 2019, according to the American brain tumor association, one of the major cause for cancer-related death is a brain cancer. It is estimated that 23,720 adults in the U.S will be diagnosed with primary cancerous tumors of the brain. Many manufacturers are focused towards development of new and innovative products to ensure a strong foot hold in the market. For an instance, NICO Corporation manufactures modern interventional technology such as BrainPath, a trans-sulcal system that may be used for standardized subcortical surgery. Furthermore, the company received FDA approval for NICO Myriad system.

Rise in adoption of minimally invasive surgery, is expected to increase the adoption of neuroendoscope devices. Furthermore, rising prevalence of brain cancer is expected to continue growth of neuroendoscopes market.  Glioblastoma is one of the most aggressive types of brain tumors. There is an increase in research for such cancers, for an instance, Brain Tumor Founder’s Collaborative (BTFC), a corporative made of 9 private organizations has granted funds for a number of studies based on glioblastoma. Adoption of robotics in healthcare and the use of robotic technology for neuroendoscopic procedure will propel the growth of neuroendoscopes market. Rise in R&D funding will support the growth of neuroendoscopes market through the forecast period. Rapid advancement in technology such as brainpath will also support the growth of Neuroendoscopes market.

Presence of alternative treatment modes such as radiation therapy and chemotherapy are anticipated to restrain the growth of neuroendoscopes market. High risk of brain surgery is one of the major factors that may affect the adoption of such procedures which may restrict the growth of the neuroendoscopes market. Increasing early diagnosis in middle and higher income countries expected to potential boost the growth of neuroendoscopes marke.t High Cost of Neuroendoscopy Procedures and equipment’s is a factors which can hinder the overall growth of neuroendoscopes market.

To remain ‘ahead’ of your competitors, request for a sample here@

https://www.persistencemarketresearch.com/samples/31449

The Neuroendoscopes Devices market is segmented by Product type, surgery and End User:

Based on the Product type Neuroendoscopes market is segmented into:

Rigid neruoendoscopes                  

  • Rigid Video neuroendoscopes
  • Rigid Fiber neuroendoscopes

Flexible neuroendoscopes 

Accessories

Based on the surgery type Neuroendoscopes market segmented into:

  • Intraventricula
  • Intracranial
  • Transnasal

Based on the end-user type Neuroendoscopes is segmented into:

  • Hospitals
  • Medical research centers

Rigid fiber neuroendoscope is one of the most common device used for many neurological diseases such as cystic lesion. However, advancements in technology has offered the development of flexible neuroendoscopes that is expected to offer lucrative growth opportunity. Based on the end-users, hospitals are expected to hold a significant revenue share in the Neuroendoscopes market owing to the large volume of procedures undertaken in these facilities. Increased research funding will support the rapid growth of revenue generated in Medical research centre

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/31449

North America is expected to lead the global Neuroendoscopes market, due to high awareness about the brain cancer, rise in adoption of brain surgery will increase the growth of Neuroendoscopes market. Rising applications of rigid endoscope in intraventricular Neuroendoscopey will also positively impact the growth of Neuroendoscopes market in the region. Europe market for neuroendoscopes is the next lucrative market owing to the advancement in technology and increasing prevalence of neurological disorders. The Asia Pacific is also expected to show significant growth in the Neuroendoscopes market due to increasing patient’s pool, well-established infrastructure and technological advancement inpatient care.

Some of the major key players in Neuroendoscopy market are: B. Braun melsungen AG, Karl Storz GmbH & Co. KG, adeor medical AG, Renishaw plc. And tonglu wanhe medical instrument Co., Ltd., Clarus medical LLC. And RUDOLF medical GmbH+Co.KG and others. These companies are also focused towards building a strong distribution network through partnership to increase their geographical presence.

Neuroendoscopes market provides analysis and information according to market segments such as geographies, product type, and industry. The research report on Neuroendoscopy market provides facts, thoughtful insight and market-validated data.

You Can Request for TOC Here @ https://www.persistencemarketresearch.com/toc/31449

Explore Extensive Coverage of PMR`s 

Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved Beg
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Top Market Insights

The Insulin Delivery Device Market To Show Constructive Disruption With US$ 14.09 Billion

Persistence Market Research Released New Market Report on “Global Market Study on Insulin Delivery Devices - Asia to Witness Highest Growth by 2020” the global insulin delivery devices market is estimated at USD 9,391.1 million in 2014 and is expected to grow at a  CAGR of 7%  from 2014 to 2020, to reach an estimated value of  USD 14,093.3 million in 2020 . The insulin delivery devices market is witnessing a significant growth due to the increasing prevalence of diabetes and rising obese endemic. In addition, advanced features of insulin delivery devices and rising awareness among people about diabetes care are also supporting in the growth of the global insulin delivery devices market. Get Going With Sample Of Insulin Delivery Device Market Report!  https://www.persistencemarketresearch.co/samples/2823 Some of the major players operating in the market: Abbott Laboratories. Novo Nordisk A/S. Eli Lilly and Company. Medtronic, Inc. Sanofi, Becton. Dickinson and Company...
Read Full Insight

The Bioinformatics Market To Grow Inadvertently

The Bioinformatics Market is bound to grow vigorously in the next 10 years. IoT has already made a beeline to the healthcare vertical. This has, in turn, enabled tracking of real-time locations of the apparatus and medical devices like scales, wheelchairs, defibrillators, or nebulizers along with remote monitoring. The entire healthcare vertical is expected to run on the IoT wave going forward.   The global  bioinformatics market  is exhibiting a  20.40% CAGR  from 2014 to 2020, according to a new market study recently released by Persistence Market Research. The market was calculated to be worth  US$4.1 bn  in 2014 and is estimated to reach  US$12.5 bn  by 2020, says PMR’s report, titled ‘ Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020 ’.   Get Going With Sample Of Bioinformatics Market Report!  https://www.persistencemarketresearch.com/samples/2778   The bioinformatics market is drive...
Read Full Insight

The Next 10 Years To Witness Formidable Growth Of Hospital Acquired Pneumonia Prevention Market (CAGR Of 4.7%) Between 2026

  The   Hospital Acquired Pneumonia Prevention Market Share   is estimated to be reaching   US$ 1,100 Million   at a   CAGR of 4.7%   from   2026 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. Over an eight-year period of assessment 2018-2026, the global market for hospital-acquired pneumonia prevention is poised to witness moderate growth, according to a recent research report on the global  hospital-acquired pneumonia prevention market . The report has been published by Persistence Market Research and is titled, “Hospital-Acquired Pneumonia Prevention Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026.” The  US$ 795 Mn  market is likely to exhibit a CAGR of 4.7%, reaching a value in exce...
Read Full Insight

The Next Decade To Sparkle With Acne Treatment Market Growing At The Rate Of 4.6% From 2025

  The   Acne Treatment Market Share   is estimated to be reaching   US$ 4,500 Million   at a   CAGR of 4.6%   from   2025 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. The average age of onset of acne has reduced from 14-15 years to 11-12 years due to changing demographics and social habits. Moreover, some of the misleading media content continue to encourage the habit of self-medication that often backfires, resulting in further complication. Over the past couple of years, demand for acne treatment drugs and medications has surged at a remarkable pace. After conducting an exclusive study, Persistence Market Research (PMR) identified that approximately 20% of the young population (aged below 13 years) suffer from moderate...
Read Full Insight

Sequential Advancements In Technology To Drive The Autogenous Vaccine For Aquaculture Market

  The   Autogenous Vaccine For Aquaculture Market Share  is expected to reach   US$ 11 Mn   between   2020 to 2030   at a   CAGR of 6% . Speedy development on the part of ICT does bring in new-fangled advantages like more autonomy to patients along with the promotion of interagency collaboration. As such, the ones with comorbidities and multidimensional problems would find themselves safe. This increased dependency is bound to drive the healthcare vertical going forward. Fish is a widely consumed food across the world. In 2019, 177.8 million metric tons of fish were produced globally. In spite of such huge production in aquaculture, bacterial disease is a major issue, and is causing multibillion-dollar losses annually. In developing countries, fish diseases often spread quickly between small-scale aquaculture farms. Rising prevalence of infectious diseases such as bacterial diseases, viral diseases, and parasitic and fungal diseases amongst fish s...
Read Full Insight

Opioids Market to Register CAGR 4.7% Increase in Revenue by 2021 End

  Persistence Market Research (PMR) delivers key insights on the Global   Opioids Market   in its latest report titled “Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period ”.The global opioids market is anticipated to exhibit a stable CAGR during the forecast period (2015-2021). By product type, the global opioids market is segmented into morphine, codeine, fentanyl, meperidine and methadone. Morphine segment was the largest contributor in overall opioids market, accounting for around 36% share in 2014. However, fentanyl segment is expected to register fastest CAGR of 4.7% during the forecast period. Synthetic opioids such as fentanyl, meperidine and methadone have lucrative growth opportunities in opioids market, owing to their potential application in opioid substitution treatment and fewer side effects as compared to natural opioids. Get Sample Copy of Report @  https://www.persis...
Read Full Insight

The Perfusion Bioreactors Market Is Expected To Grow On An Irrevocable Not At The Rate Of 7.5% Between 2021-2031

  The   Ischemic Optic Neuropathy Treatment Market Share  is expected to reach   US$ 187.7 Mn   at the rate of   3.7%   from   2021-2031 . With effective remote monitoring, the healthcare vertical is onto the awareness-building spree, so that patients could get benefited out of these services, telehealth, in particular. As such, several informative landing pages could be seen about the remote monitoring software. Ischemic optic neuropathy occurs because of a small vessel infraction of the optic nerve, and is a significant reason for impaired vision or blindness. Increasing utilization of newly approved intravitreal implants for the treatment of optic nerve disorders is expected to drive the market over the coming years. With developing awareness toward eye-associated inconveniences that give rise to impaired vision, diabetic patients and the geriatric population in developed nations are believed to have a proactive methodology for treatment-associ...
Read Full Insight

The Organic Mode Of Expansion To Dictate The Terms Of Growth For Phenylketonuria Treatment Market At The Rate Of CAGR 7% Between 2020 to 2030

  The   Phenylketonuria Treatment Market Share   is estimated to be reaching   US$ 565.8 Mn   at a   CAGR of 7%   from   2020 to 2030 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. Phenylketonuria (PKU) is an inherited disorder caused by excess of phenylalanine in the blood, which can lead to severe intellectual disabilities. There is no cure for phenylketonuria as yet, and dietary management is the only option to maintain the phenylalanine level in the body. Untreated infants with PKU tend to have unusually light eye, skin, and hair colour due to excess of phenylalanine levels interfering with melanin. Neurological symptoms such as seizures, abnormal muscle movement, tremors, or involuntary movement are some of the sympto...
Read Full Insight

Geographical Expansion To Catalyze The HPMC Capsules Market (US$ 120 Million) From 2025

  The   Global HPMC Capsules Market Share  is expected to reach   US$ 120 Million   at a CAGR of   10.9%   between   2025 . With “brand building” taking the center stage, the healthcare vertical would also be vying for brand building. In other words, increased visibility online would help the healthcare marketing service providers in making greater strides with regards to patient experience, right from drugs to treatment. HPMC capsules are strictly non-toxic and qualify to be Kosher and Halal-certified, which is why their popularity has grown in several parts of the world. Moreover, these capsules can significantly boost the body metabolism by improving absorption and digestion of protein, fat and carbohydrates. HPMC capsules find their application in the preparation of non-animal based medicines and cosmetics & nutraceuticals products. Persistence Market Research (PMR) recently conducted a study on the  global HPMC capsules market ...
Read Full Insight

The Peripheral Intravenous Catheter Market Is Expected To Grow On An Irrevocable Not At The Rate Of 7% Between 2019 to 2029

The  Global Peripheral Intravenous Catheter Market Share  is expected to reach  US$ 4.9 Billion  at a CAGR of  7%  between  2019 to 2029 . With “brand building” taking the center stage, the healthcare vertical would also be vying for brand building. In other words, increased visibility online would help the healthcare marketing service providers in making greater strides with regards to patient experience, right from drugs to treatment. Increasing hospitalizations, anticipated rise in cancer incidence, and higher demand for infused chemotherapy agents are fuelling the need for higher quality catheters for safe usage. Furthermore, rising number of biologic approvals is increasing the demand for infusion therapies. The global peripheral intravenous catheters market was valued at  US$ 4.9 Bn  in  2020 , and is expected to witness a healthy  CAGR of 7%  during the forecast period ( 2020 – 2030 ). Strategizi...
Read Full Insight